Oligonucleotide therapies: a new class of drugs that allow precise genetic targeting
Mardi 19 octobre 2021 – 15h-16h (heure de Paris)
Pr Annemieke Aartsma-Rus (Department of Human Genetics, Leiden University Medical Center, the Netherlands)
Inscription : https://us02web.zoom.us/webinar/register/WN_oWAs3Ha1SuG4Pelg17pImA
Webinaire organisé par EURO-RND (European Reference Network for Rare Neurological diseases).